Efficacy and Safety of Jiawei Suanzaoren Decoction Combined with Lorazepam for Chronic Insomnia: A Parallel-Group Randomized Controlled Trial
Table 5
SF-36 scores in two groups.
Dimensions
TG
CG
t value∗
value
Cohen’s d
Baseline
Week 12
t value
value
Baseline
Week 12
t value
value
Physical functioning
83.0 ± 3.3
92.9 ± 2.6
2.65
0.01
82.7 ± 3.1
86.4 ± 2.4
1.38
0.17
2.68
0.008
0.37
Role-physical
44.1 ± 3.3
59.9 ± 3.6
2.61
0.01
43.0 ± 3.0
56.1 ± 4.7
2.17
0.03
3.36
0.0001
0.47
Body pain
19.5 ± 5.6
2.4 ± 5.0
3.78
0.0001
20.4 ± 3.6
11.5 ± 5.6
2.51
0.01
2.47
0.01
0.34
General health
35.7 ± 2.3
67 ± 3.9
3.97
0.0001
34.3 ± 2.6
55.9 ± 3.5
2.42
0.02
2.75
0.006
0.38
Vitality
31.6 ± 1.5
63 ± 2.7
2.84
0.01
31.6 ± 1.8
53.8 ± 2.5
4.06
0.0001
4.14
0.0001
0.58
Social functioning
41.6 ± 5.0
60 ± 6.1
4.21
0.0001
42.9 ± 5.7
55.1 ± 6.3
2.22
0.03
2.66
0.008
0.37
Role-emotional
53.7 ± 7.7
86 ± 9.2
2.29
0.02
56.4 ± 7.7
69.8 ± 9.3
2.64
0.01
4.31
0.0001
0.60
Mental health
42.2 ± 6.6
68 ± 7.1
2.55
0.01
45.2 ± 6.7
64.1 ± 6.9
3.88
0.0001
2.15
0.03
0.30
TG: the treatment group, CG: the control group. Paired t-test between baseline and week 12 in the same group. Student’s t-test for score-change comparison between the two groups.
